Investigation of Metabolic and Inflammatory Disorder in the Aging FGF21 Knockout Mouse
Inflammation · 2024-12 · 47 (6) · 2173-2195
DOI: 10.1007/s10753-024-02032-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation, online erschienen am 24.04.2024. Verfasst von Lu-Qiong Cai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou Key Laboratory of Interdiscipline and Translationa…. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Mice, Knockout, Aging, Inflammation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Xinmiao Talents Program, Wenzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Aging is a physiological condition accomplished with persistent low-grade inflammation and metabolic disorders. FGF21 has been reported to act as a potent longevity determinant, involving inflammatory response and energy metabolism. In this study, we engineered aging FGF21 knockout mice of 36–40 weeks and observed that FGF21 deficiency manifests a spontaneous inflammatory response of lung and abnormal accumulation of lipids in liver. On one hand, inflamed state in lungs and increased circulating inflammatory cytokines were found in FGF21 knockout mice of 36–40 weeks. To evaluate the ability of FGF21 to suppress inflammation, a subsequent study found that FGF21 knockout aggravated LPS-induced pulmonary exudation and inflammatory infiltration in mice, while exogenous administration of FGF21 reversed these malignant phenotypes by enhancing microvascular endothelial junction. On the other hand, FGF21 knockout induces fatty liver in aging mice, characterized by excessive accumulation of triglycerides within hepatocytes. Further quantitative metabolomics and lipidomics analysis revealed perturbed metabolic profile in liver lacking FGF21, including disrupted glucose and lipids metabolism, glycerophospholipid metabolism, and amino acid metabolism. Taken together, this investigation reveals the protective role of FGF21 during aging by weakening the inflammatory response and balancing energy metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary Medicine, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, Wenzhou, Zhejian…
- School of Pharmacy, Wenzhou Medical University, Chashan University Park, Wenzhou, Zhejiang, 325000, People's Republic of China.
Förderung
- Zhejiang Xinmiao Talents Program
- Wenzhou Municipal Science and Technology Bureau
Zitieren
APA
Cai, L. Q., Li, X. C., Wang, Y. Y., Chen, Y. X., Zhu, X. Y., Zuo, Z. Y., Si-Ma, Y. Q., Lin, Y. N., Li, X. K., & Huang, X. Y. (2024). Investigation of Metabolic and Inflammatory Disorder in the Aging FGF21 Knockout Mouse. Inflammation, 47(6), 2173-2195. https://doi.org/10.1007/s10753-024-02032-3
Vancouver
Cai LQ, Li XC, Wang YY, Chen YX, Zhu XY, Zuo ZY, et al. Investigation of Metabolic and Inflammatory Disorder in the Aging FGF21 Knockout Mouse. Inflammation. 2024;47(6):2173-2195. doi:10.1007/s10753-024-02032-3
BibTeX
@article{Cai2024,
author = {Cai, Lu-Qiong and Li, Xiu-Chun and Wang, Yang-Yue and Chen, Yu-Xin and Zhu, Xia-Yan and Zuo, Zi-Yi and Si-Ma, Yi-Qun and Lin, Yi-Nuo and Li, Xiao-Kun and Huang, Xiao-Ying},
title = {Investigation of Metabolic and Inflammatory Disorder in the Aging FGF21 Knockout Mouse},
journal = {Inflammation},
year = {2024},
volume = {47},
number = {6},
pages = {2173--2195},
doi = {10.1007/s10753-024-02032-3}
}
EUVIMED